Board of Directors
A. Krenitsky, Ph.D. - President, and CEO.
Timothy J. Williams, M.B.A., J.D. -
General Counsel and Secretary.
Sylvia C. Stanat, B.A. - Treasurer.
Joseph H. Sica is
an experienced investor. Mr. Sica is an Outside Director and advises KPI on business matters.
Barry Brand is founder and CEO of K-BioPharma, a biopharma company and consulting group located near Research Triangle Park of North Carolina. Formerly, he was Vice President, Global Commercial Strategy - Neuroscience at GlaxoSmithKline PLC.
David J. Levy (J.D., Ph.D.) is a patent attorney formerly active in the North Carolina Bar. He serves as a strategic advisor to KPI on intellectual property matters with outside patent counsel. Dr. Levy was previously Vice President and Chief Patent Counsel of GlaxoSmithKline and Glaxo Wellcome Inc. in the U.S. Prior to that, he was a patent attorney with Johnson & Johnson and ICI Americas. He has a B.A. from Temple University, a Ph.D. from Brandeis University and a J.D. from the George Washington University. He is a Registered Patent Agent in the U.S.